title: Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum.
authors.affiliation: Endocrinology Service, Clinic University Hospital, University of Valencia, Spain.
authors.forename: Juan F
authors.initials: JF
authors.lastname: Ascaso
authors.forename: Arturo
authors.initials: A
authors.lastname: Fernández-Cruz
authors.forename: Pedro
authors.initials: P
authors.lastname: González Santos
authors.forename: Antonio
authors.initials: A
authors.lastname: Hernández Mijares
authors.forename: Alipio
authors.initials: A
authors.lastname: Mangas Rojas
authors.forename: Jesus
authors.initials: J
authors.lastname: Millán
authors.forename: Luis
authors.initials: L
authors.lastname: Felipe Pallardo
authors.forename: Juan
authors.initials: J
authors.lastname: Pedro-Botet
authors.forename: Francisco
authors.initials: F
authors.lastname: Pérez-Jiménez
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Pía
authors.forename: Xavier
authors.initials: X
authors.lastname: Pintó
authors.forename: Ignacio
authors.initials: I
authors.lastname: Plaza
authors.forename: Juan
authors.initials: J
authors.lastname: Rubiés-Prat
mesh_terms: D001629:Bezafibrate / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood*; D011345:Fenofibrate / Q000627:therapeutic use; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000097:blood / Q000517:prevention & control*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use; D018570:Risk Assessment
chemical_list: D008076:Cholesterol, HDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D009525:Niacin; D002784:Cholesterol; D015248:Gemfibrozil; D011345:Fenofibrate; D001629:Bezafibrate